Infantile Botulism Caused by Clostridium butyricum Type E Toxin

Pediatric Neurology

Volumn 38, Issue 1, 2008, Pages 55-57

  Abe, Yuichi ^a   Negasawa, Tetsuro ^a   Monma, Chie ^b   Oka, Akira ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN;

ANAMNESIS; ARTICLE; BOTULISM; CASE REPORT; CLINICAL FEATURE; CLOSTRIDIUM BUTYRICUM; ELECTROMYOGRAM; ELECTROPHYSIOLOGY; FECES ANALYSIS; HUMAN; INFANT; JAPAN; MALE; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL ASSAY; BOTULINUM TOXINS; BOTULISM; CLOSTRIDIUM BUTYRICUM; CONSTIPATION; ELECTRIC STIMULATION; ELECTRODIAGNOSIS; FECES; HUMANS; INFANT; MALE; MICE; NEURAL CONDUCTION; PERIPHERAL NERVES; RESPIRATORY INSUFFICIENCY;

EID: 36549007446     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2007.08.013     Document Type: Article

References (16)

1. Pickett J., Berg B., Chaplin E., and Brunstetter-Shafer M.A. Syndrome of botulism in infancy: clinical and electrophysiologic study. N Engl J Med 295 (1976) 770-772
2. Fox C.K., Keet C.A., and Strober J.B. Recent advances in infant botulism. Pediatr Neurol 32 (2005) 149-154
3. Noda H., Sugita K., Koike A., et al. Infant botulism in Asia. Am J Dis Child 142 (1988) 125-126
4. Long S.S. Botulism in infancy. Pediatr Infect Dis 3 (1984) 266-271
5. Kakinuma H., Maruyama H., Takahashi H., Yamakawa K., and Nakamura S. The first case of type B infant botulism in Japan. Acta Paediatr Jpn 38 (1996) 541-543
6. Oguma K., Yokota K., Hayashi S., et al. Infant botulism due to Clostridium botulinum type C toxin. Lancet 336 (1990) 1449-1450
7. Aureli P., Fenicia L., Pasolini B., Gianfranceschi M., McCroskey L.M., and Hatheway C.L. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis 154 (1986) 207-211
8. Fenicia L., Da Dalt L., Anniballi F., Franciosa G., Zanconato S., and Aureli P. A case if infant botulism due to neurotoxigenic Clostridium butyricum type E associated with Clostridium difficile colitis. Eur J Clin Microbiol Infect Dis 21 (2002) 736-738
9. Arnon S.S., Midura T.F., Damus K., Thompson B., Wood R.M., and Chin J. Honey and other environmental risk factors for infant botulism. J Pediatr 94 (1979) 331-336
10. Thompson J.A., Glasgow L.A., Warpinski J.R., and Olson C. Infant botulism: clinical spectrum and epidemiology. Pediatrics 66 (1980) 936-942
11. Stahl J.S., Averbuch-Heller L., Remler B.F., and Leigh R.J. Clinical evidence of extraocular muscle fiber-type specificity of botulinum toxin. Neurology 51 (1998) 1093-1099
12. Arnon S.S. Infant botulinum. In: Feigin R.D., Cherry J.D., Demmler G.J., and Kaplan S.L. (Eds). Textbook of pediatric infectious disease. 5th ed. (2004), Saunders, Philadelphia 1758-1766
13. Foran P.G., Mohammed N., Lisk G.O., et al. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A: basis for distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 278 (2003) 1363-1371
14. Billante C.R., Zealear D.L., Billante M., et al. Comparison of neuromuscular blockade and recovery with botulinum toxins A and F. Muscle Nerve 26 (2002) 395-403
15. Keet C.A., Fox C.K., Margeta M., et al. Infant botulism type F, presenting at 54 hours of life. Pediatr Neurol 32 (2005) 193-196
16. Albers J.W., Faulkner J.A., Dorovini-Zis K., Barald K.F., Must R.E., and Ball R.D. Abnormal neuromuscular transmission in an infantile myasthenic syndrome. Ann Neurol 16 (1984) 28-34